the future of mpn treatment: exciting agents and targets being investigated
Published 2 years ago • 857 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:40
the future treatment and management of mpns
-
3:21
looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment
-
1:31
novel treatment agents and how they're changing the mpn field
-
2:29
future treatment strategies for mpns
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:54
the potential role of cellular therapies and vaccines in the future treatment of mpns
-
1:51
checkpoint inhibition in the treatment of mpns
-
12:26
mds/mpn 2022 updates
-
3:40
pros and cons of ruxolitinib for the treatment of mpns
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients
-
1:49
advances in the science and treatment of mpns
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
2:16
current and future treatment approaches for hr-mds
-
1:43
ruxolitinib’s place in the future treatment landscape for mpns
-
1:26
current and emerging prognostic factors for mds/mpn
-
2:43
the management of advanced phase mpns
-
1:39
upcoming agents in et and pv
-
1:41
a look at the future treatment landscape of pnh
-
1:00
what's next for mpn?
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
1:04
the future of mds management
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸